Geode Capital Management, LLC Novavax Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Novavax Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,502,489 shares of NVAX stock, worth $28.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,502,489

Previous 3,198,330 9.51%

Holding current value

$28.2 Million

Previous $40.5 Million 9.25%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.71 - $17.11 $3.26 Million - $5.2 Million	304,159 Added 9.51%	3,502,489 $44.2 Million
Q2 2024 Aug 09, 2024	BUY	$3.89 - $20.97 $2.38 Million - $12.8 Million	610,596 Added 23.6%	3,198,330 $40.5 Million
Q1 2024 May 13, 2024	BUY	$3.76 - $6.02 $1.09 Million - $1.75 Million	290,227 Added 12.63%	2,587,734 $12.4 Million
Q4 2023 Feb 13, 2024	BUY	$4.8 - $7.67 $2.1 Million - $3.35 Million	436,530 Added 23.46%	2,297,507 $11 Million
Q3 2023 Nov 13, 2023	BUY	$6.81 - $9.74 $803,382 - $1.15 Million	117,971 Added 6.77%	1,860,977 $13.5 Million
Q2 2023 Aug 11, 2023	BUY	$6.67 - $9.52 $3.27 Million - $4.67 Million	490,352 Added 39.15%	1,743,006 $13 Million
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $896,688 - $1.94 Million	155,675 Added 14.19%	1,252,654 $8.68 Million
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $493,918 - $1.4 Million	55,747 Added 5.35%	1,096,979 $11.3 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $339,175 - $1.42 Million	18,636 Added 1.82%	1,041,232 $19 Million
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $841,587 - $1.75 Million	23,197 Added 2.32%	1,022,596 $52.6 Million
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $1.13 Million - $2.32 Million	16,229 Added 1.65%	999,399 $73.5 Million
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $3.53 Million - $5.72 Million	26,255 Added 2.74%	983,170 $141 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $13.2 Million - $20.1 Million	74,187 Added 8.4%	956,915 $198 Million
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $27.3 Million - $58 Million	-225,279 Reduced 20.33%	882,728 $187 Million
Q1 2021 May 12, 2021	BUY	$112.98 - $319.93 $16.9 Million - $47.9 Million	149,698 Added 15.62%	1,108,007 $201 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $4.67 Million - $8.27 Million	59,293 Added 6.6%	958,309 $107 Million
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $52,350 - $117,638	-659 Reduced 0.07%	899,016 $97.4 Million
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $3.93 Million - $23.7 Million	283,572 Added 46.03%	899,675 $75 Million
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $955,127 - $3.89 Million	243,035 Added 65.14%	616,103 $8.37 Million
Q4 2019 Feb 13, 2020	BUY	$3.69 - $5.22 $40,125 - $56,762	10,874 Added 3.0%	373,068 $1.48 Million
Q3 2019 Nov 12, 2019	BUY	$4.02 - $7.84 $78,293 - $152,691	19,476 Added 5.68%	362,194 $1.82 Million
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $1.69 Million - $4.18 Million	342,718 New	342,718 $2.01 Million

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Novavax Inc Transaction History